First patients sought for groundbreaking brain cancer drug trial
NCT ID NCT07185880
Summary
This is the first-ever study in people to test the safety and best dose of a new drug called MT-125 for glioblastoma, a fast-growing brain tumor. The drug is designed to be taken alongside standard radiation therapy to try to make the radiation work better. The study will enroll up to 36 adults with a newly diagnosed, specific type of glioblastoma that does not respond well to standard chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Clinic
Phoenix, Arizona, 85054, United States
Contact
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
Contact
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
Contact
Conditions
Explore the condition pages connected to this study.